Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.
Also called NCT01244763
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 145 participants
- Sponsor
- Registry
-
NCT01244763
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Puerto Rico
- Registry status
- Completed
Technical summary
Registry record NCT01244763. Randomized; no masking; primary purpose treatment. Start 2010-10-29 (actual); primary completion 2012-06-13 (actual). Results posted on 2022-02-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia
- Condition
- Chronic Kidney Disease
- Condition
- Anemia
- Intervention (Drug)
- Roxadustat
- Lead sponsor
- Kyntra Bio
- Collaborator
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01244763- Content hash
71320d2e13b54ef0d0f91171b5cf3ab6ec8b66503c39509f5c3455fb7d7080ff